glp-1 in brain A sympathetic brake on gut release: Neuron Insights into a possible role
Description
Firstly, expanding indications is a current hotspot in GLP-1 drug research
Gum disease, for instance, has been shown to make diabetes harder to manage
This is because the thyroid is regulated at several steps including two which are found in the brain
Galderma reported double-digit global growth for Sculptra in 2024
From 2008-2010, Sanofi-Aventis Acomplia (selective CB1 antagonist) and Abbott Laboratories Meridia (NE/5-HT reuptake inhibitor)--both also designed to suppress appetite--were pulled from the market over similar cardiac safety concerns
Get an estimate Self-pay In-network with most insurance plans and more
